GGrantIndex
← Leaderboards

Hua Su

University Of California, San Francisco

$11,193,749
Attributed
$11,193,749
Total exposure
6
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.1M · FY200924
$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$11,193,749 · 6

By mechanism

R01$8,910,292 · 3
R21$1,172,701 · 2
P01$1,110,756 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of California, San Francisco

Same institution · by research overlap

Others in their field

Top investigators on “Vascular Endothelial Growth Factors

Research focus

Vascular Endothelial Growth FactorsBrainPhenotypeMouse ModelGenesLesionAngiogenesisCellsEndothelial CellsPathogenesisLifeMacrophageMedicalMediatingSignal TransductionRuptureIntracranial HemorrhagesDoseNatural HistoryHemorrhageBlood VesselsAdeno-Associated Viral VectorOverexpressionAdult

Grant awards (29)

Reduction of Brain AVM Severity through Inhibition of Pathogenic Angiogenesis$556,820
R01 · FY2024 · NS · contact PI
Reduction of Brain AVM Severity through Inhibition of Pathogenic Angiogenesis$574,041
R01 · FY2023 · NS · contact PI
Uncover the Pathogenesis of Brain Arteriovenous Malformation$504,836
R01 · FY2023 · NS · contact PI
Reduction of Brain AVM Severity through Inhibition of Pathogenic Angiogenesis$574,041
R01 · FY2022 · NS · contact PI
Uncover the Pathogenesis of Brain Arteriovenous Malformation$523,483
R01 · FY2022 · NS · contact PI
Reduction of Brain AVM Severity through Inhibition of Pathogenic Angiogenesis$574,041
R01 · FY2021 · NS · contact PI
Uncover the Pathogenesis of Brain Arteriovenous Malformation$537,419
R01 · FY2021 · NS · contact PI
Reduction of Brain AVM Severity through Inhibition of Pathogenic Angiogenesis$588,018
R01 · FY2020 · NS · contact PI
Uncover the Pathogenesis of Brain Arteriovenous Malformation$525,423
R01 · FY2020 · NS · contact PI
Uncover the Pathogenesis of Brain Arteriovenous Malformation$487,576
R01 · FY2019 · NS · contact PI
Cell type-specific influences on HHT pathogenesis$391,027
R01 · FY2018 · HL · contact PI
Hemodynamics of Cerebral Arteriovenous Malformations$313,082
R01 · FY2018 · NS · contact PI
Cell type-specific influences on HHT pathogenesis$397,607
R01 · FY2017 · HL · contact PI
Hemodynamics of Cerebral Arteriovenous Malformations$313,082
R01 · FY2017 · NS · contact PI
Cell type-specific influences on HHT pathogenesis$397,019
R01 · FY2016 · HL · contact PI
Hemodynamics of Cerebral Arteriovenous Malformations$313,082
R01 · FY2016 · NS · contact PI
Cell type-specific influences on HHT pathogenesis$396,384
R01 · FY2015 · HL · contact PI
Soluble VEGF receptor therapy for brain arteriovenous malformation$395,938
R21 · FY2015 · NS · contact PI
Hemodynamics of Cerebral Arteriovenous Malformations$312,588
R01 · FY2015 · NS · contact PI
Soluble VEGF receptor therapy for brain arteriovenous malformation$394,375
R21 · FY2014 · NS · contact PI
Hemodynamics of Cerebral Arteriovenous Malformations$311,106
R01 · FY2014 · NS · contact PI
Hemodynamics of Cerebral Arteriovenous Malformations$319,617
R01 · FY2013 · NS · contact PI
Laboratory$186,805
P01 · FY2013 · NS · contact PI
Laboratory$227,361
P01 · FY2012 · NS · contact PI
Laboratory$214,346
P01 · FY2011 · NS · contact PI
Targeted Gene Expression in Ischemic Brain by Intravenous Delivery$189,263
R21 · FY2011 · NS · contact PI
Laboratory$235,933
P01 · FY2010 · NS · contact PI
Targeted Gene Expression in Ischemic Brain by Intravenous Delivery$193,125
R21 · FY2010 · NS · contact PI
Laboratory$246,311
P01 · FY2009 · NS · contact PI